Leo D. Lagasse - Concepedia

Author

Leo D. Lagasse

Also Known As

III, L D Lagasse, L LaGasse, L. D. LAGASSE, L. D. Lagasse, L. Lagasse, L.D. Lagasse, LEO D. LAGASSE, LEO LAGASSE, Leo D Lagasse

143

Publications

6.5K

Citations

H-Index

121

Concepts

All Affiliations

University of California, Los Angeles Cedars-Sinai Medical Center Gynecologic Oncology Group City Of Hope National Medical Center Oklahoma State University Center for Health Sciences

About

Leo D. Lagasse is an author at University of California, Los Angeles specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	75	5.8K
2	Public Health	10	10	993
3	Health Sciences	7	7	277
4	Allergy	1	1	42
5	Anatomy	1	1	26

Leo D. Lagasse

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Primary cytoreductive surgery for epithelial ovarian cancer. Neville F. Hacker, J. S. Berek, Leo D. Lagasse, PubMed Gynecologic SurgerySurgical OncologyPrimary Cytoreductive SurgeryGynecological SurgeryMedicine	1983	436
Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group Leo D. Lagasse, William T. Creasman, Hugh M. Shingleton, Gynecologic Oncology Intraoperative ConsultationGynecologic SurgeryCervical Cancer ManagementSurgical OncologyCervical Cancer	1980	317
Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer Robert E. Bristow, Fredrick J. Montz, Leo D. Lagasse, Gynecologic Oncology Surgical OncologyGynecological SurgeryMedicineGynecologySurgical Cytoreduction	1999	316
Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group Tate Thigpen, Hugh M. Shingleton, Howard D. Homesley, Cancer Response Rate 50Surgical OncologyResponse Rate 17GynecologyPathology	1981	294
Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA Jonathan S. Berek, Candace Howe, Leo D. Lagasse, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryMedicinePelvic Trauma	2005	263
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Neville F. Hacker, Ronald S. Leuchter, J. S. Berek, PubMed LaparoscopySurgical OncologyStage IiMinimally Invasive ProcedureSkin Bridge	1981	227
Management of Regional Lymph Nodes and their Prognostic Influence on Vulvar Cancer Neville F. Hacker, J. S. Berek, Leo D. Lagasse, Lymphoid NeoplasiaPrognostic InfluenceVulvar DiseasesMedicinePathology	1986	226
Individualization of treatment for stage I squamous cell vulvar carcinoma. Neville F. Hacker, J. S. Berek, Leo D. Lagasse, PubMed Surgical OncologyMinimally Invasive ProcedureCancer ManagementPathologyGynecology	1984	192
Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. Jonathan S. Berek, Neville F. Hacker, Alan Lichtenstein, PubMed Surgical OncologyCancer ManagementRifn-alpha 2ImmunologyGynecology	1985	182
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions Neville F. Hacker, Ronald S. Leuchter, J. S. Berek, Gynecologic Oncology LaparoscopyMinimally Invasive ProcedureThoracic SurgeryVisceral SurgerySurgery	1980	180

Page 1